In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

"I am really trying to change the traditional CFO landscape," said Mr. Firdausi during an interview with "Becker's Healthcare Podcast." "Having the PBM background, having the payer background and now ...

Owner Kenneth Bertini plans to help its staff make the move to Sear's Pharmacy in Oak Park, which will start compounding ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

Markets that cheered Trump's pro-growth agenda have turned bumpy, with oil prices and Canada and Mexico's currencies gyrating, muddled inflation forecasts shaking Treasuries and investors starting to ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

CVS Health is rolling out a new customer app that aims to make it simpler and more convenient for users to manage health ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.